Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a medicare population

American Journal of Geriatric Pharmacotherapy

Volumn 10, Issue 3, 2012, Pages 201-210

  Simoni Wastila, Linda ^a   Wei, Yu Jung ^a   Qian, Jingjing ^a,b   Zuckerman, Ilene H ^a   Stuart, Bruce ^a   Shaffer, Thomas ^a   Dalal, Anand A ^c   Bryant Comstock, Lynda ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

adherence; COPD maintenance medication; hospitalization; Medicare; spending

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; METHYLXANTHINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION CONTINUITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPORTION OF DAYS COVERED; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; MALE; MEDICARE; MEDICATION ADHERENCE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84861742706     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2012.04.002     Document Type: Article

References (43)

1. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated 2010) http://www.goldcopd.org/Guidelines/guideline- 2010-gold-report.html Accessed August 25, 2010
2. D.M. Mannino, S. Braman The epidemiology and economics of chronic obstructive pulmonary disease Proc Am Thorac Soc 4 2007 502 506 (Pubitemid 47547843)
3. Centers for Disease Control and Prevention Deaths: Preliminary Data for 2008 http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr-02.pdf 2010 Accessed February 15, 2011
4. B. Stuart, L. Simoni-Wastila, I. Zuckerman Medication Use by Age and Disabled Medicare Beneficiaries Across the Spectrum of Morbidity-A Chartbook The Peter Lamy Center on Drug Therapy and Aging 2007 University of Maryland School of Pharmacy Baltimore, MD
5. N. Jordan, T.A. Lee, M. Valenstein Effect of depression care on outcomes in COPD patients with depression Chest 135 2009 626 632
6. A.A. Dalal, M. Shah, A.O. D'Souza COPD-related healthcare utilization and costs after discharge from a hospitalization or emergency department visit on a regimen of fluticasone propionate-salmeterol combination versus other maintenance therapies Am J Manag Care 17 2011 e55 e65
7. L.A. Garcia Rodriguez, L. Cea Soriano, C. Hill Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study Neurology 76 2011 740 746
8. National Institutes of Health National Heart Lung, and Blood Institute Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases http://www.nhlbi.nih.gov/resources/docs/2009-ChartBook.pdf Accessed May 28, 2009
9. American Thoracic Society American Thoracic Society and European Respiratory Society standards for the diagnosis and management of patients with COPD http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf Accessed August 25, 2010
10. E. Jung, A.S. Pickard, J.W. Salmon Medication adherence and persistence in the last year of life in COPD patients Respir Med 103 2009 525 534
11. B.C. Stuart, L. Simoni-Wastila, I.H. Zuckerman Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease Am J Geriatr. Pharmacother 8 2010 441 453
12. J. Vestbo, J.A. Anderson, P.M. Calverley Adherence to inhaled therapy, mortality and hospital admission in COPD Thorax 64 2009 939-443
13. M.S. Charles, C.M. Blanchette, H. Silver Adherence to controller therapy for chronic obstructive pulmonary disease: a review Curr Med Res Opin 26 2010 2421 2429
14. C.S. Rand Patient adherence with COPD therapy Eur Respir Rev 14 2005 97 101 (Pubitemid 43028766)
15. R.D. Restrepo, M.T. Alvarez, L.D. Wittnebel Medication adherence issues in patients treated for COPD Int J Chron Obstruct Pulmon Dis 3 2008 371 384
16. E.L. Toy, N.U. Beaulieu, J.M. McHale Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs Respir Med 105 2011 435 441
17. N.S. Breekveldt-Postma, J. Koerselman, J.A. Erkens Enhanced persistence with tiotropium compared with other respiratory drugs in COPD Respir Med 101 2007 1398 1405 (Pubitemid 46832237)
18. J.A. Cramer, C. Bradley-Kennedy, A. Scalera Treatment persistence and compliance with medications for chronic obstructive pulmonary disease Can Respir J 14 2007 25 29 (Pubitemid 46637657)
19. L. Blais, J. Bourbeau, O. Sheehy Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment Can Respir J 11 2004 27 32 (Pubitemid 38401254)
20. A.A. Dalal, M. St Charles, H.V. Petersen Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients Int J Chron Obstruct Pulmon Dis 5 2010 179 187
21. T.E. Delea, M. Hagiwara, A.A. Dalal Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/ salmeterol vs other inhaled maintenance therapies Curr Med Res Opin 25 2009 1 13
22. M. Akazawa, D.C. Hayflinger, R.H. Stanford Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease Am J Manag Care 14 2008 438 448 (Pubitemid 352031000)
23. M. Teichert, P.A. de Smet, A. Hofman Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly Drug Saf 30 2007 541 549 (Pubitemid 46873079)
24. P.M. Ho, J.A. Spertus, F.A. Masoudi Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 2006 1842 1847 (Pubitemid 44455166)
25. M.A. De Vera, H. Choi, M. Abrahamowicz Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study Ann Rheum Dis 70 2011 1020 1024
26. Chronic Condition Data Warehouse Part D Data User Manual Buccaneer Computer Systems & Services, Inc. http://ccwdata.org/downloads/CCW-PartD- UserManual.pdf 2010 Accessed March 15, 2010
27. S.E. Andrade, K.H. Kahler, F. Frech Methods for evaluation of medication adherence and persistence using automated databases Pharmacoepidemiol Drug Saf 15 2006 565 574 discussion 75-77 (Pubitemid 44336271)
28. A.M. Peterson, D.P. Nau, J.A. Cramer A checklist for medication compliance and persistence studies using retrospective databases Value Health 10 2007 3 12 (Pubitemid 46161090)
29. S. Karve, M.A. Cleves, M. Helm An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients Med Care 46 2008 1125 1133
30. F. Zeng, B.V. Patel, L. Andrews Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens Curr Med Res Opin 26 2010 2877 2887
31. N.K. Choudhry, W.H. Shrank, R.L. Levin Measuring concurrent adherence to multiple related medications Am J Manag Care 15 2009 457 464
32. H. Ascher-Svanum, A.W. Nyhuis, V. Stauffer Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives Curr Med Res Opin 26 2010 2403 2410
33. E.Q. Wu, H.G. Birnbaum, M. Cifaldi Development of a COPD severity score Curr Med Res Opin 22 2006 1679 1687 (Pubitemid 44449224)
34. L. Simoni-Wastila, C.M. Blanchette, J. Qian Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities Am J Geriatr Pharmacother 7 2009 262 270
35. D.K. Blough, S.D. Ramsey Using generalized linear models to assess medical care costs Health Serv Outcomes Res Methodol 1 2000 185 202 (Pubitemid 32798848)
36. J. Barber, S. Thompson Multiple regression of cost data: use of generalised linear models J Health Serv Res Policy 9 2004 197 204 (Pubitemid 39424759)
37. J.R. Curtis, J. Xi, A.O. Westfall Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis Med Care 47 2009 334 341
38. W. Katon, C.R. Cantrell, M.C. Sokol Impact of antidepressant drug adherence on comorbid medication use and resource utilization Arch Intern Med 165 2005 2497 2503 (Pubitemid 41720012)
39. A.M. Yohannes, R.C. Baldwin, M. Connolly Mortality predictors in disabling chronic obstructive pulmonary disease in old age Age Ageing 31 2002 137 140 (Pubitemid 34413813)
40. P. Neuman, M.K. Strollo, S. Guterman Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors Health Aff (Millwood) 26 2007 w630 w643
41. K. Jung, A.M. McBean, J.A. Kim Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs J Manag Care Pharm 18 2012 106 115
42. C.M. Blanchette, B. Gutierrez, C. Ory Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population J Manag Care Pharm 14 2008 176 185 (Pubitemid 351453818)
43. The Centers for Medicare & Medicaid Services Hospital Quality Initiatives-Outcome Measures http://www.cms.gov/HospitalQualityInits/20- OutcomeMeasures.asp 2011 Accessed July 13, 2011